Lasmiditan
Lasmiditan
Lasmiditan (pronounced la-smi-di-tan) is a ditan molecule developed for the acute treatment of migraine. It is a selective serotonin receptor agonist.
Etymology
The term "Lasmiditan" is derived from the class of drugs it belongs to, known as "ditans". The prefix "Las" is a unique identifier for this specific molecule within the ditan class.
Pharmacology
Lasmiditan is a highly selective agonist for the 5-HT1F receptor, a subtype of the serotonin receptor. It does not constrict blood vessels, which distinguishes it from other migraine medications like triptans.
Clinical Use
Lasmiditan is used for the acute treatment of migraine with or without aura in adults. It is not indicated for the preventive treatment of migraine.
Side Effects
Common side effects of Lasmiditan include dizziness, fatigue, paresthesia, and sedation. It is contraindicated in patients with severe hepatic impairment.
Related Terms
External links
- Medical encyclopedia article on Lasmiditan
- Wikipedia's article - Lasmiditan
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski